Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador

Core Insights - Jupiter Neurosciences, Inc. has appointed Jean Fallacara as the brand ambassador for its new consumer longevity supplement line, Nugevia, which aims to enhance clinical and scientific integrity in the longevity market [2][4][5] - Nugevia is built on the JOTROL platform, a patented resveratrol-based micellar delivery system that significantly improves bioavailability, supporting the company's clinical-stage CNS therapies [5][11] - The longevity market is projected to reach $8 trillion by 2030, and Nugevia's consumer-facing strategy is expected to create a revenue stream that supports ongoing clinical development and enhances long-term shareholder value [6][8] Company Overview - Jupiter Neurosciences is a clinical-stage pharmaceutical company focused on addressing neuroinflammation and promoting healthy aging through a dual-path strategy, which includes advancing therapeutics for CNS disorders and expanding into the consumer longevity market with Nugevia [8] - The company’s therapeutic pipeline includes a Phase IIa trial for Parkinson's disease and targets other CNS disorders such as Alzheimer's Disease and Friedreich's Ataxia [8][10] - JOTROL, the foundation for both therapeutic and consumer products, has demonstrated over nine times higher bioavailability compared to earlier resveratrol products, addressing the issue of poor absorption that has historically limited the effectiveness of resveratrol [9][10][11] Product Details - Nugevia's initial formulations—GLO, MND, and PWR—are designed to support cellular resilience through synergistic ingredients optimized for absorption via the JOTROL system [5][11] - The brand emphasizes the importance of real science in wellness innovation, aiming to make human longevity accessible to a broad audience, including athletes and entrepreneurs [5][6]